We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo
ADLM 2025
Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Solvent Exposure Poses Health Risk for Pathology Workers

By LabMedica International staff writers
Posted on 07 Jul 2011
Pathologists and laboratory technicians who handle organic solvents such as toluene and xylene are at increased risk of developing autoimmune connective tissue diseases.

A new study showed an occupational health hazard involving solvent use and Raynaud’s phenomenon (RP). Other studies overseas have shown similar solvent associations, but not with people exposed to solvents at work.

“Our study of 341 medical laboratory workers indicates they are more likely to develop a condition called Raynaud’s phenomenon, if they are exposed to solvents such as toluene or xylene. This raises concerns they could then have further serious health complications later in life,” said lead investigator Gordon Purdie, at the department of medicine, University of Otago, (Wellington, New Zealand).

Raynaud’s phenomenon is characterized by vasoconstriction, or the narrowing of blood vessels in the hands and other extremities, and is characterized by pain, color changes, and tautness or fullness of the fingers or toes. For some people it is a symptom or precursor of scleroderma, a rare connective tissue disease affecting multiple systems in the body and mainly among women.

Lab workers who worked with acetone or chlorinated solvents, combined with xylene or toluene, doubled their risk of developing RP. Risk of developing severe RP was even greater, in fact nine times.

The mainly female laboratory workers (79%) who used solvents in this study had higher rates of RP. Those who had worked with xylene or toluene doubled their risk of developing severe RP.

The study was presented at the Australian Rheumatology Association Scientific Meeting in Brisbane (QLD, Australia), which was held from May 14-17, 2011. The study also appeared online in the June 2011 issue of the Journal of Rheumatology.

Related Links:

University of Otago


Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Serological Pipet Controller
PIPETBOY GENIUS
New
Anterior Nasal Specimen Collection Swabs
53-1195-TFS, 53-0100-TFS, 53-0101-TFS, 53-4582-TFS
New
Alcohol Testing Device
Dräger Alcotest 7000

Latest Technology News

Electronic Biosensors Used to Detect Pathogens Can Rapidly Detect Cancer Cells
07 Jul 2011  |   Technology

Safer, Portable and Low-Cost Imaging Solution to Revolutionize Biomedical Diagnostics
07 Jul 2011  |   Technology

Multifunctional Nanomaterial Simultaneously Performs Cancer Diagnosis, Treatment, and Immune Activation
07 Jul 2011  |   Technology



PURITAN MEDICAL